2 news items
FDA Approves Abbott's Heart Valve Repair Device For Patients At Risk Of Complications/Death During Open-Heart Surgeries
ABT
2 Apr 24
system experienced a marked improvement in their TR grade, reducing from severe or higher to moderate or less at 30 days – a reduction sustained at one
Abbott Receives FDA Approval For TriClip, First-Of-Its-Kind Device To Repair Leaky Tricuspid Heart Valve
ABT
2 Apr 24
in the severity of their symptoms and quality of life, with benefits sustained at one yearABBOTT PARK, Ill., April 2, 2024 /PRNewswire/ -- Abbott
- Prev
- 1
- Next